Arthritis, Psoriatic
Inflammatory Bowel Diseases
Off-Label Use
Ustekinumab

Ustekinumab

Ustekinumab is a medication used to manage and treat a variety of inflammatory conditions, including psoriasis, psoriatic arthritis, and inflammatory bowel disease. It is in the monoclonal antibody class of medications. This activity reviews the indications, action, and contraindications for ustekinumab as a valuable agent in treating inflammatory diseases. This activity will highlight the mechanism of action, adverse event profile, and other key factors (e.g., off-label uses, dosing, pharmacodynamics, pharmacokinetics, monitoring, relevant interactions) pertinent for members of the interprofessional team in the management of psoriasis, psoriatic arthritis, and inflammatory bowel disease.

Credit & MOC Details

Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.